Evo Fund lowers stake in Delta-Fly Pharma to 21.47%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-10-21 10:33 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 21.47%, previous report: 22.55%.